Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Psoriatic Arthritis (PsA) Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Nonsteriodal Anti-inflammatory Drugs
    • 1.4.3 Disease Modifying Antirheumatic Drugs
    • 1.4.4 Biologics
  • 1.5 Market by Application
    • 1.5.1 Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis (PsA) Treatment Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Psoriatic Arthritis (PsA) Treatment Industry
      • 1.6.1.1 Psoriatic Arthritis (PsA) Treatment Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Psoriatic Arthritis (PsA) Treatment Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Psoriatic Arthritis (PsA) Treatment Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Psoriatic Arthritis (PsA) Treatment Market Perspective (2015-2026)
  • 2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Regions
    • 2.2.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Psoriatic Arthritis (PsA) Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Psoriatic Arthritis (PsA) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Market Size
    • 3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
    • 3.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2019
  • 3.3 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
  • 3.4 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
  • 3.5 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2021-2026)

5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)
  • 5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 6.2 Psoriatic Arthritis (PsA) Treatment Key Players in North America (2019-2020)
  • 6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 7.2 Psoriatic Arthritis (PsA) Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 8.2 Psoriatic Arthritis (PsA) Treatment Key Players in China (2019-2020)
  • 8.3 China Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 8.4 China Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 9.2 Psoriatic Arthritis (PsA) Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 10.2 Psoriatic Arthritis (PsA) Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 11.2 Psoriatic Arthritis (PsA) Treatment Key Players in India (2019-2020)
  • 11.3 India Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 11.4 India Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
  • 12.2 Psoriatic Arthritis (PsA) Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Pfizer
    • 13.1.1 Pfizer Company Details
    • 13.1.2 Pfizer Business Overview and Its Total Revenue
    • 13.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020))
    • 13.1.5 Pfizer Recent Development
  • 13.2 Johnson & Johnson
    • 13.2.1 Johnson & Johnson Company Details
    • 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.2.5 Johnson & Johnson Recent Development
  • 13.3 AbbVie
    • 13.3.1 AbbVie Company Details
    • 13.3.2 AbbVie Business Overview and Its Total Revenue
    • 13.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.3.5 AbbVie Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview and Its Total Revenue
    • 13.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 UCB
    • 13.5.1 UCB Company Details
    • 13.5.2 UCB Business Overview and Its Total Revenue
    • 13.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.5.5 UCB Recent Development
  • 13.6 Roche
    • 13.6.1 Roche Company Details
    • 13.6.2 Roche Business Overview and Its Total Revenue
    • 13.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.6.5 Roche Recent Development
  • 13.7 Bristol-Myers Squibb
    • 13.7.1 Bristol-Myers Squibb Company Details
    • 13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 13.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.7.5 Bristol-Myers Squibb Recent Development
  • 13.8 Eli Lilly
    • 13.8.1 Eli Lilly Company Details
    • 13.8.2 Eli Lilly Business Overview and Its Total Revenue
    • 13.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.8.5 Eli Lilly Recent Development
  • 13.9 Amgen
    • 13.9.1 Amgen Company Details
    • 13.9.2 Amgen Business Overview and Its Total Revenue
    • 13.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.9.5 Amgen Recent Development
  • 13.10 AstraZeneca
    • 13.10.1 AstraZeneca Company Details
    • 13.10.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
    • 13.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 13.10.5 AstraZeneca Recent Development
  • 13.11 Celgene
    • 10.11.1 Celgene Company Details
    • 10.11.2 Celgene Business Overview and Its Total Revenue
    • 10.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
    • 10.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
    • 10.11.5 Celgene Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Psoriatic Arthritis (PsA) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis (PsA) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Pfizer
    Johnson & Johnson
    AbbVie
    Novartis
    UCB
    Roche
    Bristol-Myers Squibb
    Eli Lilly
    Amgen
    AstraZeneca
    Celgene

    Market segment by Type, the product can be split into
    Nonsteriodal Anti-inflammatory Drugs
    Disease Modifying Antirheumatic Drugs
    Biologics
    Market segment by Application, split into
    Hospitals
    Clinics
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Psoriatic Arthritis (PsA) Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Psoriatic Arthritis (PsA) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Psoriatic Arthritis (PsA) Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now